Low Phosphate on Admission Flags Higher Risks of Kidney Injury and Death in Hospitalized Adults

Low serum phosphate measured when patients are admitted to the hospital is an independent warning sign for both acute kidney injury and in-hospital death, according to a large retrospective study published in BMC Nephrology. The finding is notable because research on the impact of hypophosphatemia in acute kidney injury has remained limited, while prior work in this area has concentrated on the opposite end of the phosphate scale. The new analysis found that abnormally low phosphate at admission was independently associated with the development of AKI and with in-hospital mortality.

Researchers at Peking Union Medical College Hospital examined records from hospitalized adult patients admitted between January 2015 and December 2021. Rather than treating phosphate as a simple high-versus-low variable, they sorted patients into seven groups based on admission serum phosphate: below 0.81 mmol/L, then bands from 0.81 to under 0.97, 0.97 to under 1.13, 1.13 to under 1.29, 1.29 to under 1.45, and 1.45 to under 1.78 mmol/L, and finally 1.78 mmol/L or above. This grouping allowed the team to analyze the association between admission serum phosphate levels and the risks of in-hospital AKI and mortality across seven phosphate categories.

The cohort totaled 40,884 patients, and acute kidney injury was common throughout. The percentage of patients who developed AKI was 26.2 percent in the lowest phosphate band, below 0.81 mmol/L, and 40.9 percent in the highest band, at or above 1.78 mmol/L. In between, the rates were 17.4, 15.6, 14.9, 15.2, and 19.7 percent across the middle bands. The reported percentages were lowest in the middle bands and higher at both extremes, with the highest rate in the band at or above 1.78 mmol/L.

Raw percentages alone cannot settle whether phosphate is a genuine marker or merely a passenger riding along with other illnesses, so the investigators adjusted for potential confounders and ran sensitivity analyses. After adjustment, both hypophosphatemia and hyperphosphatemia remained independently associated with the development of AKI. Mortality told a sharper story. Only hypophosphatemia stayed a consistently significant independent marker associated with in-hospital death, meaning low phosphate carried prognostic weight that persisted even after the statistical models accounted for other risk factors.

The association was strongest in a clinically important subgroup. Compared with patients whose admission phosphate fell in the normal category, hypophosphatemia was independently associated with the risk of AKI and in-hospital mortality especially among patients with an estimated glomerular filtration rate above 60 ml/min/1.73m2 and among those without concurrent kidney disease. In other words, the association was most visible in patients whose baseline kidney function was relatively preserved, a group in whom a routine chemistry value might otherwise be dismissed as unremarkable.

The authors propose a biological explanation centered on proximal tubule dysfunction. Under this hypothesis, hypophosphatemia at admission would not be causing kidney injury but would function as a marker of early tubular dysfunction. The study’s conclusion frames this as shedding light on the potential role of proximal tubule dysfunction as a novel pathophysiological mechanism in AKI.

Context matters for interpreting the result. Acute kidney injury is characterized by a high incidence rate and a poor prognosis, yet it is usually detected through rising creatinine, a lag that limits how much clinicians can intervene. Prior research in this area has concentrated on the opposite end of the phosphate scale; earlier studies reported that admission hyperphosphatemia increases the risk of acute kidney injury in hospitalized patients and linked hyperphosphatemia to AKI, end-stage renal disease, and mortality. The authors note that research on the impact of hypophosphatemia in this condition has remained limited, which is the gap this study set out to address.

Several caveats should temper enthusiasm. This was a retrospective, single-center analysis of hospital records from one institution, so the findings describe associations rather than proving that correcting phosphate changes outcomes. The phosphate measurement reflects a single admission time point, and the study population, practice patterns, and case mix of one large Chinese hospital may not generalize everywhere. The article is also being shared early as a peer-reviewed accepted manuscript that carries a permanent DOI but remains subject to further edits before the final version of record is published. Whether low phosphate is a modifiable risk factor, a marker of tubular dysfunction, or both will require prospective and interventional work.

Even with those limits, the practical implication is straightforward. A phosphate value is already reported on standard metabolic panels, costs little, and is routinely drawn at admission. If the association holds in other populations, incorporating admission phosphate into early risk stratification could help flag patients, particularly those with apparently preserved kidney function, who deserve closer monitoring for AKI and for overall prognosis during hospitalization. The study does not establish that treatment should follow, but it adds a familiar, inexpensive laboratory value to the list of signals that may reveal kidney injury earlier than creatinine does.

Subject of Research: The association between admission serum phosphate levels and the risks of in-hospital acute kidney injury and mortality in hospitalized adults.

Article Title: Hypophosphatemia predicts in-hospital acute kidney injury and mortality

Article References: Xu, Y., Zheng, H., Xia, P., Wang, Y., Ye, X., Hou, F., Liu, H., Wang, K., Luo, Q., Zhou, X., & Chen, L. (2026). Hypophosphatemia predicts in-hospital acute kidney injury and mortality. BMC Nephrology. https://doi.org/10.1186/s12882-026-05437-4

Image Credits: AI Generated

DOI: 10.1186/s12882-026-05437-4

Keywords: hypophosphatemia, acute kidney injury, serum phosphate, in-hospital mortality, BMC Nephrology, retrospective study, proximal tubule dysfunction, hospitalized patients, eGFR, risk stratification, nephrology, hyperphosphatemia